<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00872365</url>
  </required_header>
  <id_info>
    <org_study_id>Colciencias 110645921540</org_study_id>
    <nct_id>NCT00872365</nct_id>
  </id_info>
  <brief_title>Effect of Micronutrients and Exercise During Pregnancy on Factors Related With Non-Transmissible Chronic Diseases</brief_title>
  <official_title>Effect of Micronutrients and Exercise During Pregnancy on Factors Related With Non-Transmissible Chronic Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad del Valle, Colombia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundación FES</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundación Cardiovascular de Colombia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto Nacional de Salud</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad del Valle, Colombia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      At the moment, most of efforts to prevent non-transmissible chronic diseases at population&#xD;
      level have been centered in promoting healthful behaviors like physical activity, consumption&#xD;
      of fruits and vegetables, and discouraging from the consumption of tobacco and alcohol in&#xD;
      adult population, but the results have been little hopeful. In the last years, manifold&#xD;
      studies have indicated the relation between metabolic alterations and of the fetal growth&#xD;
      with the development of non-transmissible chronic diseases in adult age. More recently, it&#xD;
      has been proposed that maternal factors (endothelial function, oxidative stress and&#xD;
      alterations in adipokines) and placental ones (mitochondrial dysfunction) are the precursory&#xD;
      mechanisms of fetal metabolic alterations and of the later development of non-transmissible&#xD;
      chronic diseases. Also, it has been suggested that possibly supplementation with&#xD;
      micronutrients and the physical exercise during the gestation can regulate these maternal and&#xD;
      placental factors. For the reasons just mentioned, it is necessary to clarify if these&#xD;
      proposed factors are related to fetal metabolic alterations and if the supplementation during&#xD;
      the gestation with micronutrients and/or the physical exercise can regulate them, which would&#xD;
      be an early and novel alternative to fortify the prevention of non-transmissible chronic&#xD;
      diseases in the population.&#xD;
&#xD;
      Purpose&#xD;
&#xD;
        1. To evaluate the effect of associated both the maternal and placental metabolic factors&#xD;
           to non-transmissible chronic diseases in newborn.&#xD;
&#xD;
        2. To evaluate the effect of the physical exercise and the complementation with&#xD;
           micronutrients during the pregnancy either in the endothelial function, the levels of&#xD;
           adipokines, the oxidative stress of the mother and the newborn, as in the placental&#xD;
           mitochondrial function and the anthropometry of newborn.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypothesis:&#xD;
&#xD;
        1. There is correlation between the metabolic factors, related to non-transmissible chronic&#xD;
           diseases, of the mother and those of the newborn one.&#xD;
&#xD;
        2. Supplementation with either micronutrients or physical exercise influence beneficially&#xD;
           as much in the endothelial function, oxidative stress, the levels in adipokines of the&#xD;
           mother and the newborn one like in the placental mitochondrial function.&#xD;
&#xD;
        3. The simultaneous intervention with micronutrients or physical exercise produces an&#xD;
           additional beneficial effect in the metabolic state of the mother and the newborn one.&#xD;
&#xD;
        4. The metabolic alterations when being born are not exclusive of newborn with&#xD;
           anthropometric measures located either in the inferior or superior percentiles.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelium-dependent flow mediated dilation</measure>
    <time_frame>Baseline / week 32-36 of gestation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biomarkers of endothelial function in blood from umbilical vein and maternal blood</measure>
    <time_frame>Baseline / 32-36 weeks gestation and delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Markers of mitochondrial function</measure>
    <time_frame>Baseline / 32-36 weeks gestation and delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal and maternal anthropometric indicators</measure>
    <time_frame>Baseline / 32-36 weeks gestation and delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life SF-12</measure>
    <time_frame>Baseline / 32-36 weeks gestation and delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional capacity (VO2max)</measure>
    <time_frame>Baseline / 32-36 weeks gestation and delivery</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">320</enrollment>
  <condition>Preeclampsia</condition>
  <condition>Pregnancy</condition>
  <condition>Micronutrients</condition>
  <condition>Exercise</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Regular aerobic physical exercise + placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Activities of daily living + Micronutrients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Regular aerobic exercise + micronutrients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Activities of daily living + placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Regular aerobic physical exercise</intervention_name>
    <description>Walking (10 minutes), aerobic exercise (30 minutes), stretching (10 minutes) and relaxation exercise (10 minutes). Exercise will be performed at three sessions per week. All sessions will be supervised by a physical therapist and a physical educator.</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <other_name>Intervention I</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Micronutrients</intervention_name>
    <description>Zinc 30mg, Magnesium 400mg, Beta-carotene 9 mg, Tocopherol 30mg, vitamin C 200mg y Niacin 100mg.</description>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <other_name>Intervention II</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Activities of daily living + placebo</intervention_name>
    <description>Basic activities of daily living (bathing, dressing, eating, walking) without counseling by a physical therapist and prenatal care.&#xD;
Placebo Comparator: Equivalent to placebo (maltodextrin).</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Primiparous women who have not participated in a structured exercise program,&#xD;
             including significant amounts of walking for the past four months are eligible for the&#xD;
             trial.&#xD;
&#xD;
          -  Live fetus at the routine ultrasound scan and a normal pregnancy.&#xD;
&#xD;
          -  Gestational age 16 to 20 weeks&#xD;
&#xD;
          -  Written informed consent will be obtained from each woman prior to the inclusion in&#xD;
             the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of high blood pressure&#xD;
&#xD;
          -  Chronic medical illnesses (cancer, renal, endocrinologic, psychiatric, neurologic,&#xD;
             infectious and cardiovascular diseases)&#xD;
&#xD;
          -  Persistent bleeding after week 12 of gestation&#xD;
&#xD;
          -  Poorly controlled thyroid disease&#xD;
&#xD;
          -  Placenta praevia, incompetent cervix, polyhydramnios, oligohydramnios&#xD;
&#xD;
          -  History of miscarriage in the last twelve months&#xD;
&#xD;
          -  Diseases that could interfere with participation (following recommendations from ACSM&#xD;
             2000, ACOG 2003).&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ana C Plata, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>Universidad del Valle, Colombia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julio Cesar Mateus, MD, MEpi</last_name>
    <role>Study Chair</role>
    <affiliation>Fundación FES, División de Salud. Colombia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ana C Plata, MSc</name>
      <address>
        <city>Cali</city>
        <state>Valle Del Cauca</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>March 27, 2009</study_first_submitted>
  <study_first_submitted_qc>March 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2009</study_first_posted>
  <last_update_submitted>October 10, 2018</last_update_submitted>
  <last_update_submitted_qc>October 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad del Valle, Colombia</investigator_affiliation>
    <investigator_full_name>Robinsón Ramírez</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <keyword>Pregnancy</keyword>
  <keyword>Exercise</keyword>
  <keyword>Nutrition</keyword>
  <keyword>Micronutrients</keyword>
  <keyword>non-transmissible chronic diseases</keyword>
  <keyword>Endothelium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Micronutrients</mesh_term>
    <mesh_term>Trace Elements</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

